Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Milestone Scientific ( (MLSS) ) has shared an announcement.
On August 1, 2025, Milestone Scientific Inc. announced the appointment of Eric C. Hines as the new Chief Executive Officer, effective immediately. Hines, with over 25 years of leadership experience in scaling sales-driven enterprise software companies, is expected to drive the company’s next phase of commercial execution. His appointment comes at a pivotal moment as Milestone Scientific aims to expand its presence in the medical and dental markets, leveraging recent achievements in reimbursement and the potential of its CompuFlo® technology. The company believes Hines’s expertise will help accelerate the adoption of their technology and guide them in pursuing new clinical indications and global opportunities.
The most recent analyst rating on (MLSS) stock is a Buy with a $1.25 price target. To see the full list of analyst forecasts on Milestone Scientific stock, see the MLSS Stock Forecast page.
Spark’s Take on MLSS Stock
According to Spark, TipRanks’ AI Analyst, MLSS is a Neutral.
Milestone Scientific’s overall stock score is driven by significant financial challenges, including persistent losses and negative cash flows. The bearish technical indicators further dampen the stock’s appeal. While the new board appointment is a positive development, it is insufficient to offset the financial and technical weaknesses.
To see Spark’s full report on MLSS stock, click here.
More about Milestone Scientific
Milestone Scientific Inc. is a technology-focused medical research and development company specializing in innovative injection technologies and instruments for medical and dental applications. Their computer-controlled systems aim to make injections precise and efficient, enhancing patient comfort and safety. The company utilizes its proprietary DPS Dynamic Pressure Sensing Technology® platform to develop next-generation devices for subcutaneous drug delivery, including local anesthetics.
Average Trading Volume: 93,864
Technical Sentiment Signal: Sell
Current Market Cap: $33.8M
Find detailed analytics on MLSS stock on TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money